EP4164589A1 - Cosmetic product with high degree of emptying of the preparation from the packaging - Google Patents
Cosmetic product with high degree of emptying of the preparation from the packagingInfo
- Publication number
- EP4164589A1 EP4164589A1 EP21729820.7A EP21729820A EP4164589A1 EP 4164589 A1 EP4164589 A1 EP 4164589A1 EP 21729820 A EP21729820 A EP 21729820A EP 4164589 A1 EP4164589 A1 EP 4164589A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- cosmetic
- packaging
- starch phosphate
- inci
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 83
- 239000002537 cosmetic Substances 0.000 title claims abstract description 49
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 24
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 23
- 239000001341 hydroxy propyl starch Substances 0.000 claims abstract description 21
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims abstract description 21
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 21
- 239000010452 phosphate Substances 0.000 claims abstract description 21
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims abstract description 15
- -1 compounds butylene glycol dicaprylate Chemical class 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Chemical class 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- OSORMYZMWHVFOZ-UHFFFAOYSA-N phenethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCC1=CC=CC=C1 OSORMYZMWHVFOZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229940074979 cetyl palmitate Drugs 0.000 claims description 3
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 3
- 229920001903 high density polyethylene Polymers 0.000 claims description 3
- 239000004700 high-density polyethylene Substances 0.000 claims description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 3
- 239000005022 packaging material Substances 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- PPVDHXWQWABSBC-UHFFFAOYSA-N 2-(2,6-diethyl-4-hydroxy-3,5-dimethoxyphenyl)-2-hexyl-1,3-dioxane-4,6-dione Chemical compound CCC=1C(OC)=C(O)C(OC)=C(CC)C=1C1(CCCCCC)OC(=O)CC(=O)O1 PPVDHXWQWABSBC-UHFFFAOYSA-N 0.000 claims description 2
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 claims description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 229940067596 butylparaben Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 229960000541 cetyl alcohol Drugs 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical class CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229940071160 cocoate Drugs 0.000 claims description 2
- 229940100539 dibutyl adipate Drugs 0.000 claims description 2
- 229940116365 diethylhexyl syringylidenemalonate Drugs 0.000 claims description 2
- 229940031569 diisopropyl sebacate Drugs 0.000 claims description 2
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical class CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 229960004881 homosalate Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical class CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 239000012184 mineral wax Substances 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 229960001679 octinoxate Drugs 0.000 claims description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N p-hydroxybenzoic acid propyl ester Natural products CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229940098888 phenethyl benzoate Drugs 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- PJHKBYALYHRYSK-UHFFFAOYSA-N triheptanoin Chemical compound CCCCCCC(=O)OCC(OC(=O)CCCCCC)COC(=O)CCCCCC PJHKBYALYHRYSK-UHFFFAOYSA-N 0.000 claims description 2
- 229940078561 triheptanoin Drugs 0.000 claims description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims 1
- 229940015975 1,2-hexanediol Drugs 0.000 claims 1
- 229940031723 1,2-octanediol Drugs 0.000 claims 1
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229940114374 butylene glycol dicaprylate Drugs 0.000 claims 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 claims 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004909 Moisturizer Substances 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 3
- 238000001595 flow curve Methods 0.000 description 3
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000004871 Evernia Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000001245 distarch phosphate Substances 0.000 description 2
- 235000013804 distarch phosphate Nutrition 0.000 description 2
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 239000001418 (2E)-2-benzylideneheptan-1-ol Substances 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- SBLKVIQSIHEQOF-OWOJBTEDSA-N (e)-octadec-9-enedioic acid Chemical compound OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O SBLKVIQSIHEQOF-OWOJBTEDSA-N 0.000 description 1
- HYUPHZGFPFEMDU-UHFFFAOYSA-N 1,6-diphenylhexa-1,3,5-trien-3-ol Chemical compound C(C=CC1=CC=CC=C1)=C(C=CC1=CC=CC=C1)O HYUPHZGFPFEMDU-UHFFFAOYSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- LIPHCKNQPJXUQF-SDNWHVSQSA-N 2-Benzylidene-1-heptanol Chemical compound CCCCC\C(CO)=C/C1=CC=CC=C1 LIPHCKNQPJXUQF-SDNWHVSQSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- WHBKVWBGTBULQY-UHFFFAOYSA-N 2-propylheptyl octanoate Chemical compound CCCCCCCC(=O)OCC(CCC)CCCCC WHBKVWBGTBULQY-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- FGGSPCRNKDZEKY-UHFFFAOYSA-N 3-hexoxypentane-1,2,3-triol Chemical compound CCCCCCOC(O)(CC)C(O)CO FGGSPCRNKDZEKY-UHFFFAOYSA-N 0.000 description 1
- OXYRENDGHPGWKV-UHFFFAOYSA-N 3-methyl-5-phenylpentan-1-ol Chemical compound OCCC(C)CCC1=CC=CC=C1 OXYRENDGHPGWKV-UHFFFAOYSA-N 0.000 description 1
- WCHCQZRCDHYTMF-UHFFFAOYSA-N 3-phenyl-2H-chromen-2-id-4-one Chemical class O1[C-]=C(C(=O)C2=CC=CC=C12)C1=CC=CC=C1 WCHCQZRCDHYTMF-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241000881711 Acipenser sturio Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- YEVACTAGDANHRH-UHFFFAOYSA-N Coniferan Chemical compound CCC(C)(C)C1CCCCC1OC(C)=O YEVACTAGDANHRH-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 229920003012 Hydroxypropyl distarch phosphate Polymers 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 229940090971 alpha-amylcinnamyl alcohol Drugs 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001310 hydroxy propyl distarch phosphate Substances 0.000 description 1
- DVROLKBAWTYHHD-UHFFFAOYSA-N hydroxy propyl distarch phosphate Chemical compound OC1C(O)C(OC)OC(CO)C1OC(O)CCOC1C(OC2C(C(O)C(OC3C(C(OP(O)(=O)OC4C(C(O)C(OC)OC4CO)O)C(C)OC3CO)O)OC2COC2C(C(O)C(OC)C(CO)O2)O)O)OC(CO)C(OC)C1O DVROLKBAWTYHHD-UHFFFAOYSA-N 0.000 description 1
- 235000013825 hydroxy propyl distarch phosphate Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- WIDNAJNXDPHROL-UHFFFAOYSA-N n-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide Chemical compound S1C(NC(=O)C(C)C)=NC(C=2C(=CC(O)=CC=2)O)=C1 WIDNAJNXDPHROL-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Definitions
- the present invention relates to a cosmetic made from a cosmetic preparation containing hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out, as well as a method and use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphates) in a packaging with a hole-shaped removal opening from which the cosmetic preparation can be removed by flowing out.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out as well as a method and use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphates) in a packaging with a hole-shaped removal opening from which the cosmetic preparation can be removed by flowing out.
- Skin care products usually creams, ointments or lotions, are mostly used to moisturize and re-oil the skin. Often, active ingredients are added to them that regenerate the skin and, for example, prevent and reduce its premature aging (e.g. the appearance of fine lines and wrinkles).
- cosmetics In addition to cleaning and caring for the skin, cosmetics also have an aesthetic function. They should "improve” the external appearance of the user according to the respective cultural ideas. Cosmetics thus fulfill a psychological and social function, as they increase the (visual) attractiveness of the user. This area includes, above all, “decorative” cosmetics, which change the appearance of the user with the help of dyes applied to the skin. But cleaning and care products also have a positive influence indirectly, since clean, healthy skin corresponds to people's ideal of beauty. Known ingredients such as mineral oils, silicone oils, polyacrylics are practically always bought with disadvantages with regard to the application of the products. The preparations are unattractive from a sensory point of view, which has a negative impact on the use of the products.
- the preparations become unattractive from a sensory point of view, which becomes unpleasantly noticeable, for example, when the preparation is distributed on the skin and the lack of absorption capacity.
- the replacement of mineral oils, silicone oils and polyacrylates such as carbomers, acrylates / C 10-30 alkyl acrylate cross-polymer leads to increased "whiteness" when the preparation is rubbed on the skin.
- a cosmetic consisting of a) a cosmetic preparation containing hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- the objects are also achieved through the use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in cosmetic preparations to increase the residual emptying of the preparation from a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out.
- the objects are achieved not least by a process for the production of a cosmetic with high residual emptying, characterized in that a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) is added to the preparation and b) a packaging material is selected which has a hole-shaped removal opening from which the cosmetic preparation can be removed by flowing out.
- the walls of the packaging material have a slope towards the removal opening.
- This can be seen in Figure 1 as an example.
- the slope towards the removal opening ensures that the preparation (for example under the influence of gravity) can slide down completely on the walls towards the opening without being hindered by geometric obstacles.
- Embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation contains hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation. A content of 0.5 to 2.5% by weight, based on the total weight of the preparation, is preferred according to the invention.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- Hydroxypropyl starch phosphates such as those described in US Pat. No. 6,248,338 are particularly advantageous.
- the preparation is free from polyacrylates and carbomers.
- the preparation is free from 3- (4-methylbenzylidene) -camper, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzone), 4-methoxycinnamate-2-ethylhexyl ester (INCI Octylmethoxycinnamate ), 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, homomenthyl salicylate, parabens (especially propyl and butyl paraben), methylisothiazolinone, chloromethyl isothiazolinone and DMDM hydantoin, Polyethylene glycol ethers or polyethylene glycol esters, as well as is free from mineral oils,
- Silicone oils and mineral waxes are silicone oils and mineral waxes.
- the preparation has one or more oils selected from the group of the compounds bulylene glycol docaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropyl sebacate, dicaprylyl carbonate, di-C12-13 alkyl tartrates, butyloctyl salicylate, diethylhexyl syringylidene malonate, hydragenated castor oil dimerate, triheptanoin, C12-13 alkyl lactate, C16-17 alkyl benzoate, propylheptyl caprylate, Caprylic / Capric Triglyceride,
- cococaprylate / caprate cocoglyceride, dicaprylyl ether is preferred.
- the preparation contains cococaprylate / caprate
- this component is advantageously used according to the invention in a concentration of 2 to 6% by weight, based on the total weight of the preparation.
- this component is advantageously used according to the invention in a concentration of 2 to 6% by weight, based on the total weight of the preparation.
- this component is advantageously used according to the invention in a concentration of 1 to 4% by weight, based on the total weight of the preparation.
- the preparation according to the invention is advantageously in the form of an emulsion.
- the oil-in-water emulsions (O / W emulsions) are preferred according to the invention.
- the preparation has one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl 3-methylglycose disteratate, sodium cetearyl sulfate, potassium cetylphosphate Contains stearate, sodium stearol glutamate. These can be used in the conventional concentrations.
- the packaging contains HDPE.
- the packaging means preferably consists of HDPE.
- Advantageous embodiments of the present inventions are characterized in that the preparation contains searyl alcohol and / or cetyl alcohol. According to the invention, these fatty alcohols can advantageously be used in a total concentration of 0.5 to 8% by weight, based on the total weight of the preparation, this concentration specification also applying to cases in which only one of the fatty alcohols is contained in the preparation.
- the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-decanediol, 2-methyl-1,3-propanediol, ethylhexylglycerol and / or 4- Contains flydroxyacetophenone.
- the preparation contains cetyl palmitate and / or xantham gum.
- the preparation contains cetyl palmitate, this substance is used according to the invention in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.
- the preparation contains xantham gum, this substance is advantageously used according to the invention in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.
- the preparation contains ethanol.
- ethanol is preferably used in a concentration of 3 to 8% by weight, based on the total weight of the preparation.
- Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-gluccosyl rutin, carnitine, carnosine, natural and / or synthetic Isoflavonides, flovonoids, creatine, keatinine, taurine, b-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, thiamidol, glycerylgloycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or its salts and / or licochalcone A.
- the preparation has one or more compounds selected from the group of compounds alpha-lipo
- the preparation according to the invention can advantageously contain fencing agents.
- Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of being applied or distributed to reduce the moisture release of the horny layer (also called transepidermal water loss (TEWL)) and / or to positively influence the hydration of the horny layer.
- TEWL transepidermal water loss
- Advantageous fencing agents for the purposes of the present invention are, for example, glycerine, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soy, ethylhexyloxyglycerine, pyrrolidone carboxylic acid and urea.
- polymeric moisturizers from the group of the water-soluble and / or water-swellable and / or water-gellable polysaccharides.
- hyaluronic acid chitosan and / or a fucose-rich polyscaccharide, which is available in the Chemical Abstracts under the name Fucogel®1000 from SOLABIA S.A. is available.
- Moisturizers can also be used advantageously as anti-wrinkle ingredients to protect against skin changes, such as those that occur during skin aging.
- the cosmetic preparations according to the invention can also advantageously, although not necessarily, contain fillers which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, cause or intensify a velvety or silky feel on the skin.
- Advantageous fillers for the purposes of the present invention are starch and sturgeon derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like), pigments that have neither a mainly UV filter nor coloring effect (such as boron nitride, etc.) and / ider Aerosile ® (CAS No. 7631-86-9) and / or talc.
- the preparation according to the invention contains tapioca starch and / or distarch phosphate.
- the water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number, and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanners, etc.
- customary cosmetic auxiliaries such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number, and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanners, etc.
- the preparation according to the invention has one or more perfumes selected from the group of the compounds limonene, citral, linalool, alpha-isomethyl ions, geraniol, citronellol, 2-isobuyl-4-hydroxl-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1, 1, 3,4,4, 6-hexamethyltetraling, adipic acid diester, alpha-amylcinnamyl alcohol, anise alcohol, benzoin, benzyl alcohol, benzyl benzoate, Benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, Butylphenylmethylpropioal, Cardamomöl, Cedrol, Cinnamal, Cinnamylalcohol, Cironellymethyl
- the preparation has a viscosity of 1500 to 8500 mPas, measured with the aid of a Rheomat 123 viscometer from Pro Rheo with measuring body 1.
- Embodiments of the present invention which are advantageous according to the invention are further characterized in that they have a flow limit of 9 to 23 Pa.
- the critical shear stress of the flow curve is regarded as the flow limit in the context of the present document.
- the flow curve is measured on a shear stress-controlled rheometer type SR-2000 from Rheometric Scientific at 25 ° C + 1 ° C with 25 mm plate / plate geometry with a gap between 0.8 mm and 1.2 mm, filling in a structure-friendly manner.
- a suitable constant shear stress-time-stress time ramp is specified and a corresponding structure recovery time is observed before the test and the critical shear stress is specified at the maximum of the flow curve.
- the tare weight of the packaging is first determined.
- the packaging made of the material PE in the form of a lotion bottle, with a possible
- Capacity of approx. 250 ml is filled with 200 ml of the preparation.
- the weight of the filled packaging is determined.
- the preparation is pressed out of the bottle by opening the cap, turning the bottle with the opening downwards and pressing the flanks together until no further preparation can be removed from the bottle.
- These samples are then stored upside down for several hours (4-24) with the cap closed.
- An attempt is then made again to remove the preparation from the bottle by opening the cap and squeezing the bottle with the sides until no further preparation can be removed from the bottle.
- the bottle is shaken vigorously several times with the cap closed to facilitate removal. This procedure is repeated until no more preparation can actually be removed.
- the weight of the empty packaging is determined and the remaining amount of the preparation in the bottle is calculated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Cosmetic product comprising a) a cosmetic preparation containing hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) a packaging with a dispensing opening in the form of a whole from which the cosmetic preparation can be dispensed in the form of a flow.
Description
Beschreibung description
Kosmetikum mit hoher Restentleerunq der Zubereitunq aus dem Packmittel Cosmetic with high residue emptying of the preparation from the packaging
Die vorliegende Erfindung betrifft ein Kosmetikum aus einer kosmetischen Zubereitung enthaltend Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann, sowie ein Verfahren und eine Verwendung von Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) in einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. The present invention relates to a cosmetic made from a cosmetic preparation containing hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out, as well as a method and use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphates) in a packaging with a hole-shaped removal opening from which the cosmetic preparation can be removed by flowing out.
Der Wunsch, schön und attraktiv auszusehen, ist von Natur aus im Menschen verwurzelt. Auch wenn das Schönheitsideal im Laufe der Zeit Wandlungen erfahren hat, so ist das Streben nach einem makellosen Äußeren, immer das Ziel der Menschen gewesen. Einen wesentlichen Anteil an einem schönen und attraktiven Äußeren hat dabei der Zustand und das Aussehen der Haut. The desire to look beautiful and attractive is inherently rooted in people. Even if the ideal of beauty has changed in the course of time, striving for a flawless appearance has always been the goal of people. The condition and appearance of the skin play a key role in a beautiful and attractive appearance.
Damit die Haut ihre biologischen Funktionen im vollen Umfang erfüllen kann, bedarf sie der regelmäßigen Reinigung und Pflege. Hautpflegeprodukte, in der Regel Cremes, Salben oder Lotionen, dienen meist der Befeuchtung und Rückfettung der Haut. Häufig sind ihnen Wirkstoffe zugesetzt, welche die Haut regenerieren und beispielsweise ihre vorzeitige Alterung (z.B. das Entstehen von Fältchen, Falten) verhindern und vermindern sollen. In order for the skin to be able to fully fulfill its biological functions, it needs regular cleaning and care. Skin care products, usually creams, ointments or lotions, are mostly used to moisturize and re-oil the skin. Often, active ingredients are added to them that regenerate the skin and, for example, prevent and reduce its premature aging (e.g. the appearance of fine lines and wrinkles).
Neben der Reinigung und Pflege der Haut haben Kosmetika auch eine ästhetische Aufgabe. Sie sollen das äußere Erscheinungsbild des Anwenders entsprechend den jeweiligen kulturellen Vorstellungen „verbessern“. Kosmetika erfüllen damit eine psychologisch-soziale Funktion, da sie die (optische) Attraktivität der Anwender erhöhen. In diesen Bereich fällt vor allen Dingen die „dekorative“ Kosmetik, die mit Hilfe von auf die Haut aufgetragenen Farbstoffen das Erscheinungsbild der Anwender verändert. Indirekt haben aber auch Reinigungs- und Pflegeprodukte einen positiven Einfluss, da eine saubere, gesunde Haut dem Schönheitsideal der Menschen entspricht.
bekannten Inhaltsstoffe wie Mineralöle, Silikonöle Polyacrylae wird praktisch immer mit Nachteilen im Hinblick auf die Anwendung der Produkte erkauft. Die Zubereitungen werden sensorisch unattraktiv, was auf die Anwendung der Produkte erkauft. Die Zubereitungen werden sensorisch unattraktiv, was sich beispielsweise beim Verteilen der Zubereitung auf der Haut und dem mangelnden Einzugsvermögen unangenehm bemerkbar macht. So führt unter anderem der Austausch von Mineralölen, Silikonölen und Polyacrylaten wie Carbomeren, Acrylates/C 10-30 Alkylacrylate Crosspolymer zu einem verstärkten „Weißein“ beim Verreiben der Zubereitung auf der Haut. In addition to cleaning and caring for the skin, cosmetics also have an aesthetic function. They should "improve" the external appearance of the user according to the respective cultural ideas. Cosmetics thus fulfill a psychological and social function, as they increase the (visual) attractiveness of the user. This area includes, above all, “decorative” cosmetics, which change the appearance of the user with the help of dyes applied to the skin. But cleaning and care products also have a positive influence indirectly, since clean, healthy skin corresponds to people's ideal of beauty. Known ingredients such as mineral oils, silicone oils, polyacrylics are practically always bought with disadvantages with regard to the application of the products. The preparations are unattractive from a sensory point of view, which has a negative impact on the use of the products. The preparations become unattractive from a sensory point of view, which becomes unpleasantly noticeable, for example, when the preparation is distributed on the skin and the lack of absorption capacity. For example, the replacement of mineral oils, silicone oils and polyacrylates such as carbomers, acrylates / C 10-30 alkyl acrylate cross-polymer leads to increased "whiteness" when the preparation is rubbed on the skin.
Es war daher die Aufgabe der vorliegenden Erfindung, einen Ersatz für Mineralöle und Silikonöle in kosmetischen Zubereitungen zu finden, welcher die gleichen sensorischen Eigenschaften (insbesondere im Hinblick auf das Weißein, die Verteilbarkeit auf der Haut und das Einzugsvermögen) hat, wie die Mineral- und Silikonöle. It was therefore the object of the present invention to find a substitute for mineral oils and silicone oils in cosmetic preparations which has the same sensory properties (in particular with regard to whiteness, spreadability on the skin and absorbability) as mineral and Silicone oils.
Eng verbunden mit dem Trend nach „natürlichen“ Kosmetika ist der Wunsch der Verbraucher, Kosmetika Ressourcen-sparend zu konsumieren. Neben recycelbaren Verpackungsmitteln gehört auch eine möglichst vollständige Entnahme der kosmetischen Zubereitung zu einer nachhaltigen Anwendung. Nach dem Stande der Technik bereitet es allerdings große Schwierigkeiten gerade höher-viskose, zähflüssige Zubereitungen (wie Lotion und Cremes) vollständig aus Tuben und Flaschen entnehmen zu können. Häufig bleibt eine nicht gering Restmenge im Packmittel zurück. Closely related to the trend towards “natural” cosmetics is the desire of consumers to consume cosmetics in a resource-saving manner. In addition to recyclable packaging, removal of the cosmetic preparation as completely as possible is also part of sustainable use. According to the state of the art, however, it is very difficult to be able to completely remove highly viscous, viscous preparations (such as lotions and creams) from tubes and bottles. Often a significant amount remains in the packaging.
Es war daher die Aufgabe der vorliegenden Erfindung ein Kosmetikum (d.h. eine kosmetische Zubereitung in einem Packmittel) zu entwickeln, bei dem die so genannte Restentleerung (also die möglichst vollständige Entnahme der Zubereitung aus dem Packmittel) im Vergleich zum Stande der Technik deutlich erhöht ist. It was therefore the object of the present invention to develop a cosmetic (i.e. a cosmetic preparation in a packaging) in which the so-called residual emptying (i.e. the removal of the preparation from the packaging as completely as possible) is significantly increased compared to the prior art.
Gelöst werden die Aufgaben durch ein Kosmetikum aus a) Einer kosmetischen Zubereitung enthaltend Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. The objects are achieved by a cosmetic consisting of a) a cosmetic preparation containing hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out.
Gelöst werden die Aufgaben ferner durch die Verwendung von Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) in kosmetischen Zubereitungen zur Erhöhung der Restentleerung der Zubereitung aus einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann.
Gelöst werden die Aufgaben nicht zuletzt durch ein Verfahren zur Herstellung eines Kosmetikums mit hoher Restentleerung, dadurch gekennzeichnet, dass a) der Zubereitung Hydroxypropylstärkephosphat (INCI : Hydroxypropyl Starch Phosphate) zugesetzt und b) ein Packmittel gewählt wird, welches eine lochförmige Entnahmeöffnung ausweist, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. The objects are also achieved through the use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in cosmetic preparations to increase the residual emptying of the preparation from a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out. The objects are achieved not least by a process for the production of a cosmetic with high residual emptying, characterized in that a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) is added to the preparation and b) a packaging material is selected which has a hole-shaped removal opening from which the cosmetic preparation can be removed by flowing out.
Die Formulierungen „erfindungsgemäß“, „erfindungsgemäß vorteilhaft“ etc. beziehen sich im Rahmen der vorliegenden Offenbarung immer auf das erfindungsgemäße Kosmetikum, die erfindungsgemäße Verwendung und das erfindungsgemäße Verfahren, wenn es im Einzelfall nicht anders beschrieben wird. In the context of the present disclosure, the formulations “according to the invention”, “advantageous according to the invention” etc. always relate to the cosmetic according to the invention, the use according to the invention and the method according to the invention, unless otherwise described in the individual case.
Es ist erfindungsgemäß vorteilhaft, wenn die Wände des Packmittels zur Entnahmeöffnung hin ein Gefälle ausweisen. Beispielhaft kann dies der Abbildung 1 entnommen werden. Durch das Gefälle zur Entnahmeöffnung hin ist gewährleistet, dass die Zubereitung (beispielsweise unter Einfluss der Schwerkraft) vollständig an den Wänden zur Öffnung hin Abgleiten (Herunterrutschen) kann, ohne durch geometrische Hindernisse daran gehindert zu werden. According to the invention, it is advantageous if the walls of the packaging material have a slope towards the removal opening. This can be seen in Figure 1 as an example. The slope towards the removal opening ensures that the preparation (for example under the influence of gravity) can slide down completely on the walls towards the opening without being hindered by geometric obstacles.
Erfindungsgemäß vorteilhafte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Zubereitung Hydroxypropylstärkephosphat hat (INCI: Hydroxypropyl Starch Phosphate) in einer Konzentration von 0,2 bis 5 Gewichts%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. Dabei ist ein Gehalt von 0,5 bis 2,5 Gewichts%, bezogen auf das Gesamtgewicht der Zubereitung, erfindungsgemäß bevorzugt. Embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation contains hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation. A content of 0.5 to 2.5% by weight, based on the total weight of the preparation, is preferred according to the invention.
Insbesondere vorteilhaft sind solche Hydroxypropylstärkephosphate, wie sie in der US 6248338 beschrieben werden. Ganz besonders bevorzugt ist dabei der Einsatz eines Hydroxypropyldistärkephosphates, wie es als Produkt Structure® XL der Firma Nouryon verkauft wird. Hydroxypropyl starch phosphates such as those described in US Pat. No. 6,248,338 are particularly advantageous. The use of a hydroxypropyl distarch phosphate, such as that sold as the Structure® XL product from Nouryon, is very particularly preferred.
Es ist vorteilhaft im Sinne der vorliegenden Erfindung, wenn die Zubereitung frei ist von Polyacrylaten und Carbomeren. It is advantageous for the purposes of the present invention if the preparation is free from polyacrylates and carbomers.
Darüber hinaus ist es vorteilhaft im Sinne der vorliegenden Erfindung, wenn die Zubereitung frei ist von 3-(4-Methylbenzyliden)-camper, 2-Hydroxy-4-methoxybenzophenon(INCI: Oxybenzon), 4-Methoxyzimtsäure-2-ethylhexylester (INCI Octylmethoxycinnamate), 2-Ethylhexyl-2-cyano- 3,3-diphenylacrylat, Homomenthylsalicylat, Parabenen (insbesondere Propyl- und Butylparaben), Mehylisothiazolinon, Chlormethyl-isothiazolinon und DMDM-Hydantoin,
Polyethylenglycol-ethern oder Polyethylenglycolestern, sowie frei ist von Mineralölen,In addition, it is advantageous for the purposes of the present invention if the preparation is free from 3- (4-methylbenzylidene) -camper, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzone), 4-methoxycinnamate-2-ethylhexyl ester (INCI Octylmethoxycinnamate ), 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, homomenthyl salicylate, parabens (especially propyl and butyl paraben), methylisothiazolinone, chloromethyl isothiazolinone and DMDM hydantoin, Polyethylene glycol ethers or polyethylene glycol esters, as well as is free from mineral oils,
Silikonölen und Mineralwachsen. Silicone oils and mineral waxes.
Erfindungsgemäß vorteilhaft ist es vielmehr, wenn die Zubereitung ein oder mehrere Öle gewählt aus der Gruppe der Verbindungen Bulylene Glycol Docaprylat/Dicaprat, Phenethyl Benzoat, C12-15 Alkyl Benzoat, Dibutyladipat; Diisopropylsebacate, Dicaprylylcarobnat, Di-C12- 13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate, Triheptanoin, C12-13 Alkyl Lactate, C16-17 Alkyl Benzoate, Proylheptyl Caprylate, Diethylhexyl 2,6-Nephthalate, Octyldodecanol, Caprylic/Capric Triglyceride,Rather, it is advantageous according to the invention if the preparation has one or more oils selected from the group of the compounds bulylene glycol docaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropyl sebacate, dicaprylyl carbonate, di-C12-13 alkyl tartrates, butyloctyl salicylate, diethylhexyl syringylidene malonate, hydragenated castor oil dimerate, triheptanoin, C12-13 alkyl lactate, C16-17 alkyl benzoate, propylheptyl caprylate, Caprylic / Capric Triglyceride,
Ethylhexyl Cocoate,Cocoaprylate/caprate, Cocoglyceride, Dicaorylyether, enthält. Erfindungsgemäß bevorzugt ist dabei der Einsatz von Cococaprylate/caprate, Cocoglyceride, Dicaprylylether. Contains ethylhexyl cocoate, cocoaprylate / caprate, cocoglyceride, dicaorylyether. According to the invention, the use of cococaprylate / caprate, cocoglyceride, dicaprylyl ether is preferred.
Enthält die Zubereitung Cococaprylate/caprate, so wird diese Komponente erfindungsgemäß vorteilhaft in einer Konzentration von 2 bis 6 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt. If the preparation contains cococaprylate / caprate, this component is advantageously used according to the invention in a concentration of 2 to 6% by weight, based on the total weight of the preparation.
Enthält die Zubereitung Cocoglyceride, so wird diese Komponente erfindungsgemäß vorteilhaft in einer Konzentration von 2 bis 6 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt. If the preparation contains cocoglycerides, this component is advantageously used according to the invention in a concentration of 2 to 6% by weight, based on the total weight of the preparation.
Enthält die Zubereitung Dicaprylylether so wird diese Komponente erfindungsgemäß vorteilhaft in einer Konzentration von 1 bis 4 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt. If the preparation contains dicaprylyl ether, this component is advantageously used according to the invention in a concentration of 1 to 4% by weight, based on the total weight of the preparation.
Die erfindungsgemäße Zubereitung liegt erfindungsgemäß vorteilhaft in Form einer Emulsion vor. Dabei sind die ÖI-in-Wasser-Emulsion (O/W-Emulsionen) erfindungsgemäß bevorzugt. According to the invention, the preparation according to the invention is advantageously in the form of an emulsion. The oil-in-water emulsions (O / W emulsions) are preferred according to the invention.
In einem solchen Fall ist es erfindungsgemäß vorteilhaft, wenn die Zubereitung einen oder mehrere O/W-Emulgatoren gewählt aus der Gruppe der Verbindungen Glycerylstearatcitrat, Glycerylstearat (selbstemulgierend), Stearinsäure, Stearatsalze, Polyglyceryl-3- methylglycosedisteratat, Natriumcetearylsulfat, Kaliumcetylphosphat, Polyglyceryl-10 Stearat, Natriumstearolglutamat, enthält. Diese können in den herkömmlichen Einsatzkonzentrationen eingesetzt werden. In such a case it is advantageous according to the invention if the preparation has one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl 3-methylglycose disteratate, sodium cetearyl sulfate, potassium cetylphosphate Contains stearate, sodium stearol glutamate. These can be used in the conventional concentrations.
Im Hinblick auf das Packmittel ist es erfindungsgemäß von Vorteil, wenn das Packmittel HDPE enthält. Erfindungsgemäß bevorzugt besteht das Packmittel aus HDPE.
Vorteilhafte Ausführungsformen der vorliegenden Erfindungen sind dadurch gekennzeichnet, dass die Zubereitung Searylalkohol und/oder Cetylalkohol enthält. Diese Fettalkohole können erfindungsgemäß vorteilhaft in einer Gesamtkonzentration von 0,5 bis 8 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt werden, wobei diese Konzentrationsangabe auch für die Fälle gilt, bei denen nur einer der Fettalkohole in der Zubereitung enthalten ist. With regard to the packaging, it is advantageous according to the invention if the packaging contains HDPE. According to the invention, the packaging means preferably consists of HDPE. Advantageous embodiments of the present inventions are characterized in that the preparation contains searyl alcohol and / or cetyl alcohol. According to the invention, these fatty alcohols can advantageously be used in a total concentration of 0.5 to 8% by weight, based on the total weight of the preparation, this concentration specification also applying to cases in which only one of the fatty alcohols is contained in the preparation.
Es ist vorteilhaft, im Sinne der vorliegenden Erfindung, wenn die Zubereitung ein oder mehrere Alkandiole aus der Gruppe der Verbindungen 1 ,2-Pentandiol, 1 ,2-Decandiol, 2-Mehyl-1 ,3- propandiol, Ethylhexylglycerin und/oder 4-Flydroxyacetophenon enthält. For the purposes of the present invention, it is advantageous if the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-decanediol, 2-methyl-1,3-propanediol, ethylhexylglycerol and / or 4- Contains flydroxyacetophenone.
Ferner werden erfindungsgemäß vorteilhafte Ausführungsformen dadurch erhalten, dass die Zubereitung Cetylpalmitat und/oder Xanthamgummi enthält. Furthermore, advantageous embodiments according to the invention are obtained in that the preparation contains cetyl palmitate and / or xantham gum.
Enthält die Zubereitung Cetylpalmitat, so wird diese Substanz erfindungsgemäß in einer Konzentration von 0,5 bis Gewichts 5%, bezogen auf das Gesamtgewicht der Zubereitung eingesetzt. If the preparation contains cetyl palmitate, this substance is used according to the invention in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.
Enthält die Zubereitung Xanthamgummi, so wird diese Substanz erfindungsgemäß vorteilhaft in einer Konzentration von 0,5 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung eingesetzt. If the preparation contains xantham gum, this substance is advantageously used according to the invention in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.
Es ist erfindungsgemäß vorteilhaft, wenn die Zubereitung Ethanol enthält. Ethanol wird erfindungsgemäß bevorzugt in einer Konzentration von 3 bis 8 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung eingesetzt. It is advantageous according to the invention if the preparation contains ethanol. According to the invention, ethanol is preferably used in a concentration of 3 to 8% by weight, based on the total weight of the preparation.
Erfindungsgemäß vorteilhafte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Zubereitung eine oder mehrere Verbindungen gewählt aus der Guppe der Verbindungen alpha-Liponsäure, Folsäure, Phytoen, D-Biotin, Coenzym Q10, alpha- Gluccosylrutin, Carnitin, Carnosin, natürliche und/odersynthetische Isoflavonide, Flovonoide, Kreatin, Keatinin, Taurin, b-Alanin, Panthenol, Magnolol, Honokiol, Tocopherylacetat, Dihydroxyaceton; 8-Hexadecen-1 , 16-dicarbonsäure, Thiamidol, Glycerylgloycose, (2- Hydroxyethyl)harnstoff, Vitamin E bzw. seine Derivate, Hyaluronsäure und/oder deren Salze und/oder Licochalcon A enthält. Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-gluccosyl rutin, carnitine, carnosine, natural and / or synthetic Isoflavonides, flovonoids, creatine, keatinine, taurine, b-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, thiamidol, glycerylgloycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or its salts and / or licochalcone A.
Die erfindungsgemäße Zubereitung kann vorteilhaft Fechthaltemittel enthalten. Als Feuchthaltemittel (Moisturizer) werden Stoffe oder Stoffgemische bezeichnet, welche kosmetischen Zubereitungen die Eigenschaft verleihen, nach dem Aufträgen bzw. Verteilen auf
der Hautoberfläche die Feuchtigkeitsabgabe der Hornschicht (auch transepidermal water loss (TEWL genannt) zu reduzieren und/oder die Hydration der Hornschicht positiv zu beeinflussen. The preparation according to the invention can advantageously contain fencing agents. Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of being applied or distributed to reduce the moisture release of the horny layer (also called transepidermal water loss (TEWL)) and / or to positively influence the hydration of the horny layer.
Vorteilhafte Fechthaltemittel (Moisturizer) im Sinne der vorliegenden Erfindung sind beispielsweise Glycerin, Milchsäure und/oder Lactate, insbesondere Natriumlactat, Butylenglykol, Propylenglykol, Biosaccaride Gum-1 , Glycine Soja, Ethylhexyloxyglycerin, Pyrrolidoncarbonsäure und Harnstoff. Ferner ist es insbesondere von Vorteil, polymere Moisturizer aus der Gruppe der wasserlöslichen und/oder in Wasser quellbaren und/oder mit Hilfe von Wasser gelierbaren Polysaccharide zu verwenden. Insbesondere von Vorteil sind beispielsweise Hyaluronsäure, Chitosan und/oder ein fucosereiches Polyscaccharid, welches in den Chemical Abstracts unter der Bezeichnung Fucogel®1000 von der Gesellschaft SOLABIA S.A. erhältlich ist. Moisturizer können vorteilhaft auch als Antifaltenwirkstoffe zum Schutz vor Hautveränderungen, wie sie z.B. bei der Hautalterung auftreten, verwendet werden. Advantageous fencing agents (moisturizers) for the purposes of the present invention are, for example, glycerine, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soy, ethylhexyloxyglycerine, pyrrolidone carboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of the water-soluble and / or water-swellable and / or water-gellable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan and / or a fucose-rich polyscaccharide, which is available in the Chemical Abstracts under the name Fucogel®1000 from SOLABIA S.A. is available. Moisturizers can also be used advantageously as anti-wrinkle ingredients to protect against skin changes, such as those that occur during skin aging.
Die erfindungsgemäßen kosmetischen Zubereitungen können ferner vorteilhaft, wenngleich nicht zwingen, Füllstoffe enthalten, welche z.B. die sensorischen und kosmetischen Eigenschaften der Formulierungen weiter verbessern und beispielsweise ein samtiges oder seidiges Hautgefühl hervorrufen oder verstärken. Vorteilhafte Füllstoffe im Sinne der vorliegenden Erfindung sind Stärke und Störkederivate (wie z.B. Tapiocastärke, Distärkphosphat, Aluminum- bzw. Natrium-Stärke Octenylsuccinat und dergleichen), Pigmente, die weder hauptsächlich UV-Filter- noch färbende Wirkung haben (wie z.B. Bornitrid etc) und/ider Aerosile® (CAS-Nr. 7631-86-9) und/oder Talkum. The cosmetic preparations according to the invention can also advantageously, although not necessarily, contain fillers which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, cause or intensify a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are starch and sturgeon derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like), pigments that have neither a mainly UV filter nor coloring effect (such as boron nitride, etc.) and / ider Aerosile ® (CAS No. 7631-86-9) and / or talc.
Es ist erfindungsgemäß bevorzugt, wenn die erfindungsgemäße Zubereitung Tapiokastärke und/oder Distärkephospat enthält. It is preferred according to the invention if the preparation according to the invention contains tapioca starch and / or distarch phosphate.
Die Wasserphase der erfindungsgemäßen Zubereitungen kann vorteilhaft übliche kosmetische Hilfstoffe enthalten, wie beispielsweise Alkohole, insbesondere solche, niedriger C-Zahl, vorzugsweise Ethanol und/oder Isopropanol oder Polyole niedriger C-Zahl sowie deren Ether, vorzugsweise Propylenglykol, Glycerin, Elektrolyte, Selbstbräuner etc. The water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number, and their ethers, preferably propylene glycol, glycerol, electrolytes, self-tanners, etc.
Es ist ferner vorteilhaft im Sinne der vorliegenden Erfindung, wenn die erfindungsgemäße Zubereitung einen oder mehrere Parfümstoffe gewählt aus der Gruppe der Verbindungen Limonen, Citral, Linalool, alpha-lsomethylionen, Geraniol, Citronellol, 2-lsobuyl-4-hydroxl-4-methyltetrahydropyran, 2-tert-Pentylcyclohexylacetat, 3-Methyl-5-phenyl-1-pentanol, 7-Acetyl-1 ,1 ,3,4,4, 6-hexamethyltetraling, Adipinsäurediester, alpha-Amylcinnamylalkohol, Anisalkohol, Benzoin, Benzylakohol, Benzylbenzoat, Benzylcinnamat, Benzylsalicylat, Bergamotöl, bitteres Orangenöl,
Butylphenylmethylpropioal, Cardamomöl, Cedrol, Cinnamal, Cinnamylalkohol, Cironellymethylcrotonat, Cironenöl, Coumarin, Diethylsuccinat, Ethyllinalool, Eugenol, Evernia Furfuracea Extract, Evernia Prunastri Extract, Farnesol, Guajakholzöl, Hexylcinnamal, Hexylsalicylat, Hydroxycetonellal, Lavendelöl, Lemonenöl, Linaylacetat, Mandarinenöl, Methyl PCA, Mehylheptenon, Muskatussöl, Rosmarinöl, süßesIt is also advantageous in the context of the present invention if the preparation according to the invention has one or more perfumes selected from the group of the compounds limonene, citral, linalool, alpha-isomethyl ions, geraniol, citronellol, 2-isobuyl-4-hydroxl-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1, 1, 3,4,4, 6-hexamethyltetraling, adipic acid diester, alpha-amylcinnamyl alcohol, anise alcohol, benzoin, benzyl alcohol, benzyl benzoate, Benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, Butylphenylmethylpropioal, Cardamomöl, Cedrol, Cinnamal, Cinnamylalcohol, Cironellymethylcrotonat, Cironenöl, Coumarin, Diethylsuccinat, Ethyllinalool, Eugenol, Evernia Furfuracea Extract, Evernia Prunalamelamal, Lavycayellat, Hexylcinnastrietat, Hydroxycet, Hexylcinnastrietatöl, Hexylcinnastrietat, Hexylcinnastrietat, Hexylcinneletat, Hexylcinneletat , Mehylheptenone, Nutmeg Oil, Rosemary Oil, Sweet
Orangenöl, Terpineol, Tonkabohnenöl, Triethylcitrat und/oder Vanillin enthält. Contains orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.
Es ist erfindungsgemäß von Vorteil, wenn die Zubereitung eine Viskosität von 1500 bis 8500 mPas aufweist, gemessen mit Hilfe eines Viskosimeters des Typs Rheomat 123 von Pro Rheo mit dem Messkörper 1. According to the invention, it is advantageous if the preparation has a viscosity of 1500 to 8500 mPas, measured with the aid of a Rheomat 123 viscometer from Pro Rheo with measuring body 1.
Erfindungsgemäß vorteilhafte Ausführungsformen der vorliegenden Erfindung sind ferner dadurch gekennzeichnet, dass sie eine Fließgrenze von 9 bis 23 Pa aufweisen. Als Fließgrenze im Sinne der vorliegenden Schrift wird die kritische Schubspannung der Fließkurve angesehen. Embodiments of the present invention which are advantageous according to the invention are further characterized in that they have a flow limit of 9 to 23 Pa. The critical shear stress of the flow curve is regarded as the flow limit in the context of the present document.
Gemessen wird die Fließkurve auf einem schubspannungsgesteuerten Rheometer Typ SR-2000 der Firma Rheometric Scientific bei 25°C + 1°C mit 25 mm Platte/Platte Geometrie bei einem Spalt zwischen 0,8 mm und 1 ,2 mm, wobei strukturschonend befüllt wird. Es wird eine geeignete konstante Schubspannungszeitspannungszeitrampe vorgegeben und vor dem Test eine entsprechende Strukturerholungszeit eingehalten und die kritische Schubspannung im Maximum der Fließkurve angegeben.
The flow curve is measured on a shear stress-controlled rheometer type SR-2000 from Rheometric Scientific at 25 ° C + 1 ° C with 25 mm plate / plate geometry with a gap between 0.8 mm and 1.2 mm, filling in a structure-friendly manner. A suitable constant shear stress-time-stress time ramp is specified and a corresponding structure recovery time is observed before the test and the critical shear stress is specified at the maximum of the flow curve.
Vergleichsversuch/Ausführungsbeispiel Comparative experiment / exemplary embodiment
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitung bezogen.
The following examples are intended to illustrate the present invention without restricting it. Unless otherwise stated, all quantities, proportions and percentages are based on the weight and the total amount or on the total weight of the preparation.
Ausführung execution
Das Taragewicht der Packmittel wird zunächst ermittelt. Die Packmittel aus dem Material PE in Form einer Lotionflasche, mit einem möglichenThe tare weight of the packaging is first determined. The packaging made of the material PE in the form of a lotion bottle, with a possible
Fassungsvolumen von ca. 250 ml, werden mit 200 ml der Zubereitung gefüllt. Capacity of approx. 250 ml is filled with 200 ml of the preparation.
Die Packmittel aus dem Material PE in Form einer Lotionflasche (Geometrie siehe Abbildung), mit einem möglichen Fassungsvolumen von ca. 400 ml, werden mit 350 ml der Zubereitung gefüllt. Das Gewicht der gefüllten Packmittel wird ermittelt.
Nun wird die Zubereitung aus der Flasche herausgedrückt, indem die Kappe geöffnet-, die Flasche mit der Öffnung nach unten gedreht- und mit den Fländen zusammengedrückt wird, so lange bis keine Zubereitung mehr aus der Flasche entnehmbar ist. Diese Muster werden im Anschluss für mehrere Stunden (4-24) mit geschlossener Kappe kopfüber gelagert. Danach wird wieder versucht, die Zubereitung aus der Flasche zu entnehmen, indem die Kappe geöffnet und die Flasche mit den Fländen zusammengedrückt wird, so lange bis keine Zubereitung mehr aus der Flasche entnehmbar ist. Ggf. wird zur Erleichterung der Entnahme die Flasche mehrmals kräftig mit geschlossener Kappe senkrecht geschüttelt. Diese Vorgehensweise wird so lange wiederholt, bis tatsächlich keine Zubereitung mehr entnehmbar ist. The packaging made of the material PE in the form of a lotion bottle (geometry see illustration), with a possible capacity of approx. 400 ml, is filled with 350 ml of the preparation. The weight of the filled packaging is determined. Now the preparation is pressed out of the bottle by opening the cap, turning the bottle with the opening downwards and pressing the flanks together until no further preparation can be removed from the bottle. These samples are then stored upside down for several hours (4-24) with the cap closed. An attempt is then made again to remove the preparation from the bottle by opening the cap and squeezing the bottle with the sides until no further preparation can be removed from the bottle. If necessary, the bottle is shaken vigorously several times with the cap closed to facilitate removal. This procedure is repeated until no more preparation can actually be removed.
Das Gewicht der entleerten Packmittel wird ermittelt und die Restmenge der Zubereitung in der Flasche errechnet. The weight of the empty packaging is determined and the remaining amount of the preparation in the bottle is calculated.
Abmessungen Lotion Flasche 200 ml: Dimensions lotion bottle 200 ml:
Flöhe: 17 cm Breite: 6,3 cm Fleas: 17 cm. Width: 6.3 cm
Abmessungen Lotion Flasche 350 ml: Dimensions lotion bottle 350 ml:
Flöhe: 20 cm Breite: 7,3 cm Fleas: 20 cm. Width: 7.3 cm
Bestellunmmern der Verpackungen: Order numbers of the packaging:
Flasche (Alpha Nobeljas): Bottle (Alpha Nobeljas):
200ml - 65952-90025-00 350ml - 25649-20025-00 Kappen (Berry Spain): 200ml - 65952-90025-00 350ml - 25649-20025-00 caps (Berry Spain):
Kappe - 65953-90025-00
Cap - 65953-90025-00
Versuchsergebnis Restentleerung
Test result residual emptying
Claims
1. Kosmetikum aus a) einer kosmetischen Zubereitung enthaltend Hydroxyproylstärkephosphat (INCI : Hydroxyprophyl Starch Phosphate) und b) einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. 1. Cosmetic consisting of a) a cosmetic preparation containing hydroxyproyl starch phosphate (INCI: Hydroxyprophyl Starch Phosphate) and b) a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out.
2. Verwendung von Hydroxypropylstärkephoshat (INCI: Hydroxypropyl Starch Phosphate) in kosmetischen Zubereitungen zur Erhöhung der Restentleerung der Zubereitung aus einem Packmittel mit lochförmiger Entnahmeöffnung, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. 2. Use of hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in cosmetic preparations to increase the residual emptying of the preparation from a packaging with a perforated removal opening from which the cosmetic preparation can be removed by flowing out.
3. Verfahren zur Herstellung eines Kosmetikums mit hoher Restentleerung, dadurch gekennzeichnet, dass a) der Zubereitung Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) zugesetzt und b) ein Packmittel gewählt wird, welches eine lochförmige Entnahmeöffnung aufweist, aus dem die kosmetische Zubereitung durch Ausfließen entnommen werden kann. 3. A method for producing a cosmetic with high residual emptying, characterized in that a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) is added to the preparation and b) a packaging material is selected which has a perforated removal opening from which the cosmetic preparation is removed by flowing out can be.
4. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Wände des Packmittels zur Entnahmeöffnung hin ein Gefälle aufweisen. 4. Cosmetic, use or method according to one of the preceding claims, characterized in that the walls of the packaging means have a slope towards the removal opening.
5. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung Hydroxypropylstärkephospat (INCI: Hydroxypropyl Starch Phosohate) in einer Konzentration von 0,2 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. 5. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation contains hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.
6. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung frei ist von Plyacrylaten und Carbomeren. 6. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation is free from polyacrylates and carbomers.
7. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung frei ist von 3-(4- Methylbenzyliden)-campher, 2-Hydroxy-4-methoxybenzophenon (INCI: Oxybenon), 4-Methoxyzimtsäure-2-ethylhexylester (INCI Octylmethoxycinnamate), 2-Ethylhexyl- 2-cyano-3,3-dophenylarylat, Homomenthylsalicylat, Parabenenen (insbesondere Propyl- und Butylparaben), Methylisothiazolinon, Chlormethyl-isothiazolinon und DMDM-Hydantoin, Polyethylenglycolethern oder Polyethylenglycolestern, sowie frei ist von Mineralölen, Silikonölen und Mineralwachsen. 7. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation is free from 3- (4-methylbenzylidene) camphor, 2-hydroxy-4-methoxybenzophenone (INCI: oxybenone), 4-methoxycinnamic acid-2 -ethylhexyl ester (INCI Octylmethoxycinnamate), 2-ethylhexyl-2-cyano-3,3-dophenylarylate, homomenthyl salicylate, parabens (especially propyl and butyl paraben), methylisothiazolinone, chloromethyl-isothiazolinone and DMDM-hydantoin, polyethylene glycol esters, and free of polyethylene glycol ethers Mineral oils, silicone oils and mineral waxes.
8. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung ein oder mehrere Öle
gewählt aus der Gruppe der Verbindungen Butylene Glycol Dicaprylat/Dicaprat, Phenethyl Benzoat, C12-15 Alkyl Benzoat, Dibutyladipat; Diisopropylsebacate, Dicarylylcaronat, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate, Triheptanoin, C12-13 Alkyl Lactate, C16-17 Alkyl Benzoae, Propylheptyl Carpylate, Diethylhexyl 2,6- Naphthalate, Octydodecanol, Caprylic/Capric Triglyceride, Ethylhexyl Cocoate, Cocoglyceride, Dicaprylylether, enthält. 8. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation has one or more oils selected from the group of the compounds butylene glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropyl sebacate, dicarylyl carbonate, di-C12-13 alkyl tartrates, butyloctyl salicylate, diethylhexyl syringylidene malonate, hydragnated castor oil dimerate, triheptanoin, C12-13 alkyl lactate, C16-17 alkyl benzoae, propylheptyl carpylate, 2,6- alkyl naphthalene, diethylhexylate Contains Caprylic / Capric Triglyceride, Ethylhexyl Cocoate, Cocoglyceride, Dicaprylylether.
9. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere O/W-Emulgatoren gewählt aus der Verbindung Glycerylstearatcitrat, Glycerylstearat, (selbstemulgieren), Stearinsäure, Stearatsalze, Polyglyceryl-3- methylglycosedistearat, Natriumcetearylsulfat, Kalimcetylphosphat, Polyglyceryl-10 Stearat, Natriumstearoylglutatmat, enthält. 9. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation has one or more O / W emulsifiers selected from the compound glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, sodium cetearyl sulfate , Potassium cetyl phosphate, polyglyceryl-10 stearate, sodium stearoyl glutatmatate.
10. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass das Packmittel HDPE enthält. 10. Cosmetic, use or method according to one of the preceding claims, characterized in that the packaging contains HDPE.
11. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung Stearylalkohol und/oder Cetylalkohol enthält. 11. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation contains stearyl alcohol and / or cetyl alcohol.
12. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung ein oder mehrere Alkandiole aus der Gruppe der Verbindungen 1 ,2-Pentandiol, 1 ,2-Hexyandiol, 1 ,2- Octandiol, 1 ,2-Decandiol, 2-Methyl-1 ,3-propandiol, Ethylhexylglycerin und/oder 4- Hydroxyacetonphenon enthält. 12. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation contains one or more alkanediols from the group of compounds 1, 2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2- Contains decanediol, 2-methyl-1, 3-propanediol, ethylhexylglycerol and / or 4-hydroxyacetone phenone.
13. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung Cetylpalmitat und/oder Xanthamgummi enthält. 13. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation contains cetyl palmitate and / or xantham gum.
14. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung eine Viskosität von 1800 bis 8500 mPas aufweist, gemessen mit Hilfe eines Viskosimeters des Typs Rheomat 123 von pro Rheo mit dem Messkörper 1. 14. Cosmetic, use or method according to one of the preceding claims, characterized in that the preparation has a viscosity of 1800 to 8500 mPas, measured with the aid of a Rheomat 123 viscometer from pro Rheo with measuring body 1.
15. Kosmetikum, Verwendung oder Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass sie eine Fließgrenze von 9 bis 23 Pa aufweisen.
15. Cosmetic, use or method according to one of the preceding claims, characterized in that they have a flow limit of 9 to 23 Pa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102020003488.8A DE102020003488A1 (en) | 2020-06-10 | 2020-06-10 | Cosmetic with a high level of emptying of the preparation from the packaging |
PCT/EP2021/063713 WO2021249751A1 (en) | 2020-06-10 | 2021-05-21 | Cosmetic product with high degree of emptying of the preparation from the packaging |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4164589A1 true EP4164589A1 (en) | 2023-04-19 |
Family
ID=76269704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21729820.7A Pending EP4164589A1 (en) | 2020-06-10 | 2021-05-21 | Cosmetic product with high degree of emptying of the preparation from the packaging |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230277430A1 (en) |
EP (1) | EP4164589A1 (en) |
BR (1) | BR112022025064A2 (en) |
DE (1) | DE102020003488A1 (en) |
WO (1) | WO2021249751A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627498A1 (en) | 1996-07-08 | 1998-01-15 | Nat Starch Chem Invest | Starchy cleaning and care products |
DE102011079062A1 (en) * | 2011-05-02 | 2012-11-08 | Beiersdorf Ag | Use of surface-treated containers, functions- and system-packagings and applicators for providing and applying cosmetic and/or dermatological preparations |
DE102011077028A1 (en) | 2011-06-07 | 2012-12-13 | Beiersdorf Ag | Cosmetic or dermatological preparations with improved rheological properties |
FR3002141B1 (en) | 2013-02-21 | 2015-06-26 | Oreal | OIL-IN-WATER EMULSION COMPRISING AT LEAST ONE SPECIFIC MIXTURE OF NON-IONIC SURFACTANTS, A WAX COMPRISING AT LEAST ONE ESTER AND A WATER-SOLUBLE POLYSACCHARIDE |
DE102018214479A1 (en) * | 2018-08-28 | 2020-03-05 | Beiersdorf Ag | Acrylic-free cosmetic emulsion |
-
2020
- 2020-06-10 DE DE102020003488.8A patent/DE102020003488A1/en active Pending
-
2021
- 2021-05-21 US US18/000,965 patent/US20230277430A1/en active Pending
- 2021-05-21 WO PCT/EP2021/063713 patent/WO2021249751A1/en unknown
- 2021-05-21 BR BR112022025064A patent/BR112022025064A2/en unknown
- 2021-05-21 EP EP21729820.7A patent/EP4164589A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021249751A1 (en) | 2021-12-16 |
DE102020003488A1 (en) | 2021-12-16 |
BR112022025064A2 (en) | 2022-12-27 |
US20230277430A1 (en) | 2023-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996028132A2 (en) | Cosmetic or dermatological gels based on microemulsions | |
EP3890684A1 (en) | O/w emulsion comprising rhamnolipids | |
WO2013120829A2 (en) | Stable water-in-oil emulsions with spreadable oils | |
WO2012167906A2 (en) | Cosmetic or dermatological preparations with improved rheological properties | |
KR101465109B1 (en) | The cosmetic composition both promoting a skin elasticity and improving a skin wrinkles in a short time and manufacturing method there of | |
WO2018224413A1 (en) | Alkane diols in salt-containing cosmetic preparations | |
EP2603194B1 (en) | Stabilized w/o emulsions | |
DE102005051862A1 (en) | Emulsion for treating e.g. skin aging comprises a lipid phase of polar and/or moderately polar, having specified interfacial tension toward water; and at least one 1,2-alkanediol having specified 1-octanol/water distribution coefficient | |
EP3661605B1 (en) | Cosmetic for facial cleansing | |
WO2021249751A1 (en) | Cosmetic product with high degree of emptying of the preparation from the packaging | |
DE102005051864A1 (en) | Cosmetic oil-in-water emulsion for, e.g. ointment, cream, or low-viscosity lotion, includes 1,2-hexanediol, and oil-in-water emulsifiers | |
DE102018217678A1 (en) | Cosmetic foam suitable for crucible products and their manufacture | |
EP3761946B1 (en) | Fruit acid-containing cosmetic gel | |
EP3993768A1 (en) | Lipid mixture consisting of liquid oils, hydrogenated vegetable oils, and shea butter | |
WO2013120825A2 (en) | Stable water-in-oil emulsions with improved sensory properties | |
WO2022008192A1 (en) | Fragrance-stable cosmetic preparation | |
WO2021037716A1 (en) | Particularly natural oil substitute for cosmetic preparations | |
DE102019212792A1 (en) | Oil substitutes for cosmetic preparations | |
WO2020048838A1 (en) | Hydrodispersion with panthenol | |
EP4021380A1 (en) | Particularly natural oil substitute for cosmetic preparations | |
DE202010011395U1 (en) | Stabilized W / O emulsions | |
DE102005051861A1 (en) | Cosmetic water-in-oil-emulsion, useful as spray or as soaking medium for plaster or cloth, comprises 1,2-hexanediol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230110 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BEIERSDORF AG |